Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Neurovascular Interventional Devices	573.02M
Neurovascular Interventional Devices Growth	35.82%
Peripheral-vascular Interventional Devices	273.68M
Peripheral-vascular Interventional Devices Growth	71.22%
Other	1.68M
Other Growth	16.51%
Other	1.68M
Other Growth	16.51%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Other	24.48M
Other Growth	55.22%
China	823.90M
China Growth	45.21%
Other	24.48M
Other Growth	55.22%